Answers are grounded in this paper and cite their sources.
Monodisperse Pt and Pt-M (M = Co, Ru) alloy nanoparticles supported on carbon black (Pt/CB, Pt(2)Ru(3)/CB, Pt(3)Co/CB) were prepared by the nanocapsule method. We have succeeded in controlling the particle size simply by changing the molar ratio of metal precursor(s) to surfactant (M/S) in the preparation, with the other conditions being identical. The particle size was well-controlled between 2.0 and 4.5 nm with a metal loading level of 50 wt % for all catalysts. The compositions of the alloy particles were close to the projected values, with a small standard deviation, i.e., <3.1 atom % for Pt(2)Ru(3) and 1.4 atom % for Pt(3)Co. It was also found that these alloys were in the form of the corresponding solid solutions with the fcc structure.
No takes yet. Share an insight, caveat, or question.
Okaya et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: